Malin Thulin-Hagberg
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Adrenal-derived factors drive progression of sclerotic prostate cancer in bone.
Journal: Endocrine-related cancer
Published: August 11, 2025
Testosterone exacerbates neutrophilia and cardiac injury in myocardial infarction via actions in bone marrow.
Journal: Nature communications
Published: March 14, 2024
Targeting sex steroid biosynthesis for breast and prostate cancer therapy.
Journal: Nature reviews. Cancer
Published: July 20, 2023
Dietary Progesterone Contributes to Intratissue Levels of Progesterone in Male Mice.
Journal: Endocrinology
Published: April 26, 2023
The roles of RUNX2 and osteoclasts in regulating expression of steroidogenic enzymes in castration-resistant prostate cancer cells.
Journal: Molecular and cellular endocrinology
Published: January 01, 2021
Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors.
Journal: EJNMMI research
Published: November 18, 2019
Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis.
Journal: Molecular and cellular endocrinology
Published: June 03, 2015
Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies.
Journal: Clinical & experimental metastasis
Published: April 23, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026